GCM
MRK icon

Genus Capital Management’s Merck MRK Stock Holding History

Genus Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,479
Closed -$446K – 299
2024
Q4 		$446K Sell
4,479
-54,112
-92% -$5.58M 0.06% 144
2024
Q3 		$6.65M Sell
58,591
-92,782
-61% -$11M 0.87% 36
2024
Q2 		$18.7M Buy
+151,373
New +$19.5M 2.47% 2
2024
Q1 		– Sell
-174,013
Closed -$19M – 325
2023
Q4 		$19M Buy
+174,013
New +$18.1M 2.78% 5

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Genus Capital Management's MRK Position: Q1 2026 in Review

Genus Capital Management increased its Merck (MRK) stake by 86% in Q1 2026, buying an estimated $5.49M and bringing the position to 102,986 shares worth $12.4M. The position accounts for 1.42% of the portfolio, ranked #20.

Genus Capital Management first reported a position in MRK in Q2 2023 and has held it in 7 quarters since. The position peaked at $22.4M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Genus Capital Management held 102,986 shares of Merck worth $12.4M as of Q1 2026.
  • Genus Capital Management bought 47,533 Merck shares in Q1 2026, an estimated $5.49M.
  • Merck made up 1.42% of Genus Capital Management's portfolio in Q1 2026, its #20 holding.
  • Genus Capital Management first reported a position in Merck in Q2 2023 and has held it in 7 quarters since.
  • Genus Capital Management's Merck position peaked at $22.4M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.